161 related articles for article (PubMed ID: 26702262)
1. Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect.
Venkatesh DN; Baskaran M; Karri VV; Mannemala SS; Radhakrishna K; Goti S
Saudi Pharm J; 2015 Nov; 23(6):667-74. PubMed ID: 26702262
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
Parvathaneni V; Goyal M; Kulkarni NS; Shukla SK; Gupta V
Pharm Res; 2020 Jun; 37(7):123. PubMed ID: 32514688
[TBL] [Abstract][Full Text] [Related]
3. Novel nelfinavir mesylate loaded d-α-tocopheryl polyethylene glycol 1000 succinate micelles for enhanced pediatric anti HIV therapy: In vitro characterization and in vivo evaluation.
Moretton MA; Taira C; Flor S; Bernabeu E; Lucangioli S; Höcht C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Nov; 123():302-10. PubMed ID: 25270729
[TBL] [Abstract][Full Text] [Related]
4. Enhanced oral bioavailability of acetylpuerarin by poly(lactide-co-glycolide) nanoparticles optimized using uniform design combined with response surface methodology.
Sun D; Xue A; Zhang B; Xue X; Zhang J; Liu W
Drug Des Devel Ther; 2016; 10():2029-39. PubMed ID: 27382256
[TBL] [Abstract][Full Text] [Related]
5. Clarithromycin-Loaded Poly (Lactic-
Öztürk AA; Yenilmez E; Özarda MG
Polymers (Basel); 2019 Oct; 11(10):. PubMed ID: 31600969
[TBL] [Abstract][Full Text] [Related]
6. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
7. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
8. Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: Design, optimization and evaluation.
Wang F; Shan Q; Chang X; Li Z; Gui S
Int J Pharm; 2021 Jun; 602():120617. PubMed ID: 33887394
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity.
Haggag YA; Abosalha AK; Tambuwala MM; Osman EY; El-Gizawy SA; Essa EA; Donia AA
Biopharm Drug Dispos; 2021 Jan; 42(1):12-23. PubMed ID: 33320969
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
11. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
12. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
[TBL] [Abstract][Full Text] [Related]
13. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of Orally Delivered Alpha-Tocopherol by Poly(Lactic-Co-Glycolic) Acid (PLGA) Nanoparticles and Chitosan Covered PLGA Nanoparticles in F344 Rats.
Simon LC; Stout RW; Sabliov C
Nanobiomedicine (Rij); 2016; 3():8. PubMed ID: 29942383
[TBL] [Abstract][Full Text] [Related]
15. Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome.
Anwer MK; Al-Shdefat R; Ezzeldin E; Alshahrani SM; Alshetaili AS; Iqbal M
Front Pharmacol; 2017; 8():844. PubMed ID: 29209215
[TBL] [Abstract][Full Text] [Related]
16. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
17. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
18. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
19. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
[TBL] [Abstract][Full Text] [Related]
20. The studies of PLGA nanoparticles loading atorvastatin calcium for oral administration
Li Z; Tao W; Zhang D; Wu C; Song B; Wang S; Wang T; Hu M; Liu X; Wang Y; Sun Y; Sun J
Asian J Pharm Sci; 2017 May; 12(3):285-291. PubMed ID: 32104340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]